CME (CME Group) Marketable Securities: $124 Mil (As of Mar. 2026)


CME CME Group Inc CME
80 GF Score
Price $243.07
GF Value $271.42
Valuation Modestly Undervalued
! 3 Warning Signs
View Full Analysis

What is CME Group Marketable Securities?

CME Group CME +0.96% 80 Marketable Securities is $124 Mil as of Mar. 2026. GuruFocus rates CME with a GF Score™ of 80/100 and a GF Value™ of $271.42 (Modestly Undervalued). The stock has 3 warning signs investors should review.

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price. CME Group's Marketable Securities for the quarter that ended in Mar. 2026 was $124 Mil.

CME Group's annual Marketable Securities increased from Dec. 2023 ($112 Mil) to Dec. 2024 ($113 Mil) and increased from Dec. 2024 ($113 Mil) to Dec. 2025 ($125 Mil).

CME Group  (NAS:CME) Marketable Securities Explanation

Marketable Securities are very liquid as they tend to have maturities of less than one year. Furthermore, the rate at which these securities can be bought or sold has little effect on their prices.

Please note, GuruFocus' Marketable Securities also includes "Other Short Term Investment".

CME Group Marketable Securities Related Terms

CME Group Marketable Securities Historical Data

* Premium members only.

The historical data trend for CME Group's Marketable Securities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

CME Group Marketable Securities Chart

CME Group Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Marketable Securities
Get a 7-Day Free Trial Premium Member Only Premium Member Only 115.00 96.00 111.70 113.20 125.00

CME Group Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Marketable Securities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 113.90 117.60 123.20 125.00 124.20
CME
80GF Score
CME Group Inc CME
Marketable Securities is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

CME Group Marketable Securities Calculation

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price.

Frequently Asked Questions Learn more about Marketable Securities →
What does a Marketable Securities of $124 Mil mean?
CME Group (CME) has a Marketable Securities of $124 Mil as of Mar. 2026. Marketable securities are high-liquid securites not directly classified as cash or cash equivalents. View historical data on CME Group and its competitors.
Is CME Group's Marketable Securities too high?
CME Group's current Marketable Securities is $124 Mil. Overall, CME Group has a GF Score™ of 80/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does CME Group's Marketable Securities compare to MCO and ICE?
CME Group's Marketable Securities of $124 Mil can be compared against companies in the Capital Markets industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Marketable Securities for a Capital Markets company?
A good Marketable Securities depends on the Capital Markets industry context. However, Marketable Securities should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Marketable Securities mean?
A high Marketable Securities can signal that a stock is expensive relative to its fundamentals. Marketable securities are high-liquid securites not directly classified as cash or cash equivalents. View historical data on CME Group and its competitors. CME Group's current Marketable Securities is $124 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is CME Group stock overvalued right now?
Based on GuruFocus' analysis, CME Group (CME) is currently considered Modestly Undervalued. The stock's GF Value™ is $271.42, compared to a current price of $243.07 — trading 10.4% below its estimated fair value. The current Marketable Securities is $124 Mil. CME Group's overall GF Score™ is 80/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Marketable Securities calculated?
Marketable Securities is calculated from a company's financial statements. For CME Group (CME), the current Marketable Securities is $124 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is CME Group (CME) Overvalued in 2026?

Based on GuruFocus' analysis, CME Group stock appears to be undervalued. The current stock price of $243.07 is trading 10.4% below its estimated GF Value™ of $271.42. GuruFocus considers CME Group to be Modestly Undervalued.

Key valuation signals for CME:

  • Marketable Securities: $124 Mil
  • GF Value™: $271.42 vs. price of $243.07 (10.4% below fair value)
  • GF Score™: 80/100 with 3 warning signs

No single metric tells the full story. See the CME stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

CME Group Business Description

Address 20 South Wacker Drive, Chicago, IL, USA, 60606
Based in Chicago, CME Group operates exchanges giving investors, suppliers, and businesses the ability to trade futures and derivatives based on interest rates, equity indexes, foreign currencies, energy, metals, and commodities. The Chicago Mercantile Exchange was founded in 1898 and in 2002 completed its IPO. Since then, CME Group has consolidated parts of the industry by merging with crosstown rival CBOT Holdings in 2007 before acquiring Nymex Holdings in 2008 and NEX in 2018. In addition, the company has a 27% stake in S&P Dow Jones Indexes, making the Chicago Mercantile Exchange the exclusive venue to trade and clear S&P futures contracts. Through CME's acquisition of NEX, it also expanded into cash foreign exchange, fixed-income trading, and collateral optimization.
80GF Score

Get the complete analysis for CME

Marketable Securities is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$243.07
Price
$271.42
GF Value